Therapeutic Advantage of Targeting PRMT5 in Combination with Chemotherapies or EGFR/HER2 Inhibitors in Triple-Negative Breast Cancers
-
Published:2023-11
Issue:
Volume:Volume 15
Page:785-799
-
ISSN:1179-1314
-
Container-title:Breast Cancer: Targets and Therapy
-
language:en
-
Short-container-title:BCTT
Author:
Dakroub Rayan,
Huard Solène,
Hajj-Younes Yara,
Suresh Samyuktha,
Badran Bassam,
Fayyad-Kazan Hussein,
Dubois ThierryORCID
Publisher
Informa UK Limited
Cited by
3 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献